Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Biomolecules ; 9(10)2019 10 11.
Article in English | MEDLINE | ID: mdl-31614639

ABSTRACT

We investigated whether short term high fructose intake may induce early hepatic dysfunction in rats and to test whether allopurinol treatment may have beneficial effects. Twenty male Sprague-Dawley rats received 20% fructose in drinking water (10 treated with allopurinol and 10 received vehicle) and 10 control rats received tap water. After 14 days, the hepatic response to an acute fructose load was evaluated, and in fasted animals, respirometry studies in freshly isolated mitochondria were performed. In fasting rats, we did not find differences in systemic or hepatic uric acid and triglyceride concentrations among the groups, but mitochondrial respiratory control rate was significantly decreased by high fructose feeding and correlated with a reduced expression of Complex I, as well as decreased aconitase-2 activity. On the other hand, in fructose fed rats, an acute fructose load increased systemic and hepatic uric acid, triglycerides and oxidative stress. Fructose feeding was also associated with fructokinase and xanthine oxidase overexpression and increased liver de novo lipogenesis program (fatty acid synthase (FAS) and cell death-inducing DFFA-like effector C (CIDEC) overexpression, ATP citrate lyase (ACL) and acetyl coA carboxylase (ACC) overactivity and decreased AMP-activated protein kinase (AMPk) and endothelial nitric oxide synthase (eNOS) activation). Allopurinol treatment prevented hepatic and systemic alterations. These data suggest that early treatment with xanthine oxidase inhibitors might provide a therapeutic advantage by delaying or even halting the progression of non-alcoholic fatty liver disease (NAFLD).


Subject(s)
Allopurinol/pharmacology , Fructose/antagonists & inhibitors , Lipogenesis/drug effects , Non-alcoholic Fatty Liver Disease/drug therapy , Administration, Oral , Allopurinol/administration & dosage , Animals , Apoptosis/drug effects , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Fructose/administration & dosage , Fructose/pharmacology , Male , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Rats , Rats, Sprague-Dawley
2.
Clin J Am Soc Nephrol ; 11(8): 1472-1483, 2016 08 08.
Article in English | MEDLINE | ID: mdl-27151892

ABSTRACT

Climate change has led to significant rise of 0.8°C-0.9°C in global mean temperature over the last century and has been linked with significant increases in the frequency and severity of heat waves (extreme heat events). Climate change has also been increasingly connected to detrimental human health. One of the consequences of climate-related extreme heat exposure is dehydration and volume loss, leading to acute mortality from exacerbations of pre-existing chronic disease, as well as from outright heat exhaustion and heat stroke. Recent studies have also shown that recurrent heat exposure with physical exertion and inadequate hydration can lead to CKD that is distinct from that caused by diabetes, hypertension, or GN. Epidemics of CKD consistent with heat stress nephropathy are now occurring across the world. Here, we describe this disease, discuss the locations where it appears to be manifesting, link it with increasing temperatures, and discuss ongoing attempts to prevent the disease. Heat stress nephropathy may represent one of the first epidemics due to global warming. Government, industry, and health policy makers in the impacted regions should place greater emphasis on occupational and community interventions.


Subject(s)
Climate Change , Epidemics , Extreme Heat/adverse effects , Heat Stress Disorders/epidemiology , Renal Insufficiency, Chronic/epidemiology , Central America/epidemiology , Dehydration/etiology , Heat Stress Disorders/etiology , Humans , India/epidemiology , North America/epidemiology , Physical Exertion , Renal Insufficiency, Chronic/etiology , South America/epidemiology , Sri Lanka/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL